i3 Consult to Expand It's CTR Reporting for Observational Studies in Pre-Approval and Post Marketing for Mobile OS Application
Back in December last year i3 Consult launched its CTRReporting Services for Observational Studies ().
Just to re-iterate the unique selling point of these
services, i3 Consult through its weekly clinical trial reports (CTR) on
new drug therapies currently in clinical trials worldwide, we are seeking
to use our CTR database as real world evidence in helping our clients to
address the following critical success issues:
• Is the research
sufficiently patient-focused?
• Have sufficient
observational studies been used in the pre-approval and post market stages?
• Are there further
opportunities for observational study data to save you time and money in your
current clinical trial investigation?
• How observational studies
can make a viable alternative to clinical trials or bridging studies.
• To identify stakeholders
and determine what kind of observational research data is needed.
At
i3 Consult we believe that Mobile OS applications can be harnessed in clinical
trials to identify blind spots and moreover address novel clinical endpoints that
would have been impractical or intractable based on previous modes of
clinical trial reporting. Mobile OS Application derived observational
studies particularly at the pre-approval or even post marketing
stages of clinical trials have the added benefit of being more efficient
and patient friendly to trial participants while contributing to the real world
patient focused understanding of the sponsor’s candidate medicine
otherwise gathered in isolated clinical or research settings.
We
will continue to develop and expand in this exciting area as the Clinical
Trials Transformation Initiative (CTTI) unfolds and more and more of our
clients come to realise the enormous potential of such technology-derived
novelty.
Comments
Post a Comment